Actinium Pharmaceuticals's total assets for Q1 2025 were $68.65M, a decrease of -10.73% from the previous quarter. DE:7AY1 total liabilities were $42.95M for the fiscal quarter, a -2.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.